R
Roland E. Schmieder
Researcher at University of Erlangen-Nuremberg
Publications - 780
Citations - 85811
Roland E. Schmieder is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Blood pressure & Essential hypertension. The author has an hindex of 97, co-authored 717 publications receiving 78138 citations. Previous affiliations of Roland E. Schmieder include Complutense University of Madrid & University of Regensburg.
Papers
More filters
Journal ArticleDOI
Subtotal nephrectomy impairs ischemia-induced angiogenesis and hindlimb re-perfusion in rats
Johannes Jacobi,Markus Porst,Nada Cordasic,Barbara Namer,Roland E. Schmieder,K.-U. Eckardt,Karl F. Hilgers +6 more
TL;DR: Chronic renal insufficiency impairs angiogenesis and limb perfusion in a rat hindlimb ischemia model may contribute to the poor prognosis of patients with renal failure suffering from peripheral arterial disease.
Journal ArticleDOI
Biventricular cardiac hypertrophy in essential hypertension
Boris D. Nunez,Franz H. Messerli,Celso Amodeo,Guillermo E. Garavaglia,Roland E. Schmieder,Edward D. Frohlich +5 more
TL;DR: Right ventricular hypertrophy is associated with LVH in patients with hypertension, although the changes of LVH are frequently more obvious to the clinician, and suggests early diastolic functional involvement of the left ventricle in hypertension.
Journal ArticleDOI
Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease.
Peter Bramlage,Stephanie L. Swift,Martin Thoenes,Joan Minguet,C. Ferrero,Roland E. Schmieder +5 more
TL;DR: Pre-clinical and clinical evidence suggests that finerenone may achieve equivalent organ-protective effects with reduced levels of electrolyte disturbance compared with traditional steroid-based MR antagonists, which supports further clinical development offinerenone for the treatment of cardiovascular and renal disease.
Journal ArticleDOI
AT1-receptor blockade improves augmentation index: a double-blind, randomized, controlled study.
Arnfried U. Klingbeil,Stefan John,Markus P. Schneider,Johannes Jacobi,Gottfried Weidinger,Roland E. Schmieder +5 more
TL;DR: Blood pressure reduction with the AT1 receptor antagonist valsartan but not with hydrochlorothiazide reduced the augmentation index in essential hypertension.
Journal ArticleDOI
Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and the European Society of Hypertension (ESH).
Pasquale Perrone-Filardi,Antonio Coca,Maurizio Galderisi,Stefania Paolillo,Francisco Alpendurada,Giovanni de Simone,Erwan Donal,Thomas Kahan,Giuseppe Mancia,Josep Redon,Roland E. Schmieder,Bryan Williams,Enrico Agabiti-Rosei +12 more
TL;DR: The aim of this article is to provide the community of cardiology with an update on appropriate and justified use of non-invasive imaging tests in the growing population of hypertensive patients.